Detalhe da pesquisa
1.
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).
Haemophilia
; 19(1): 76-81, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22823000
2.
Adenotonsillectomy in patients with desmopressin responsive mild bleeding disorders: a review of the literature.
Haemophilia
; 16(5): 711-6, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20028423
3.
Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
J Thromb Haemost
; 13(9): 1585-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25930155
4.
Nonsurgical therapy of splenic rupture in a hemophiliac.
J Pediatr Surg
; 27(4): 523-4, 1992 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-1522472
5.
Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo.
J Thromb Haemost
; 10(11): 2328-37, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22908929
6.
High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.
Haemophilia
; 7(3): 258-66, 2001 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11380629
7.
Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
Blood
; 91(5): 1572-81, 1998 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9473222